EnChroma Launches New Color Blind Glasses Engineered for Strong Protans

Wednesday, November 14, 2018 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

Technological Lens Innovation Offers New Solutions for One of the Most Challenging Forms of Color Blindness

BERKELEY, Calif., Nov. 14, 2018 /PRNewswire-PRWeb/ -- EnChroma, Inc. – creators of glasses for color blindness –

today announced the new EnChroma® Cx3 Sun SP™ lens, a new lens specially engineered for people with strong protan-type color vision deficiency (CVD). The Cx3 Sun SP lens delivers a broader range of clear, vibrant color optimized to assist the visual needs of individuals with strong protanomaly.

The Cx3 Sun SP lens is now available online at EnChroma.com and will also be available through Authorized EnChroma Eye Care Professionals in mid-November. All styles of EnChroma glasses for adults and kids can be made with this new addition to the lens lineup that includes the best-selling Cx3 Sun Outdoor lens and the Cx1 Indoor lens, each engineered for different categories of lighting conditions.

"Building on more than ten years of research and innovation, we're excited to bring vibrant color to strong protans, a group particularly challenged by color blindness because they typically see an even more limited range of color compared to the average color vision deficient individual," said Andrew Schmeder, CEO and Co-founder of EnChroma. "To offer a solution specifically for this underserved group is a testament to our ability to develop technology for color blindness that enables access to color for all."

"I've been wearing EnChroma glasses for nearly three years now and I'm still overwhelmed by the colorful world I'm able to appreciate every day," said Joyce Watters of Roseville, Calif., a color blind IT account manager. "Life is so much richer and better in beautiful color. EnChroma glasses make colors more distinct and radiant than I ever could have imagined."

Strong protans struggle to see red, and colors containing red, and are often more acutely affected by their condition. People with strong protanomaly represent up to 10% of the estimated 300 million people worldwide with blindness.

"The EnChroma SP lens for strong protans is a game-changer because it provides the color blind with more individualized solutions," said Master Optician Barry Santini of Long Island Opticians in Seaford, New York. "I appreciate that my color blind patients can now try EnChroma lenses for all types of red-green color blindness including mild, moderate and strong forms."

Color blindness affects one in 12 men (8%), and one in 200 women (.5%) – roughly 300 million worldwide, and an estimated 13 million in the United States. EnChroma lenses enable red-green color blind people to see a broader range of clear, vibrant color. Special optical filters in the lenses remove small slices of light from the visible spectrum to establish a more accurate ratio of light entering the eye. This enables the color blind to experience a more normal spectral response and participate more fully in life's colorful moments.

About EnChroma EnChroma, Inc. develops lens technologies and high-performance eyewear for color blindness. Co-founded by a Ph.D. glass scientist and UC Berkeley educated mathematician, EnChroma invented award-winning glasses for color blindness that combine the latest in color perception neuroscience and lens innovation to enable access to color for all. Based in Berkeley, California, EnChroma received a SBIR grant from the National Institute of Health (NIH) and earned the 2016 Tibbetts Award from the U.S. Small Business Administration in recognition of the firm's innovative impact on the human experience through technology. EnChroma also received the 2017 Beacons of the Photonics Industry Award from Photonics Media. For more information please call 510-497-0048 or visit EnChroma.com.

 

SOURCE EnChroma



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store